Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the “Company”) today announced that management will participate in the following upcoming investor conferences, which are being conducted in-person in New York City:

• Morgan Stanley 22nd Annual Global Healthcare Conference: Fireside chat on Thursday, September 5, 2024, at 1:50pm ET
• Baird 2024 Global Healthcare Conference: Fireside chat on Tuesday, September 10, 2024, at 3:45pm ET
• H.C. Wainwright 26th Annual Global Investment Conference: Corporate presentation on Wednesday, September 11, 2024, at 8:30am ET

A live webcast of each conference event can be accessed under “Events and Presentations” in the Investor section of the Company’s website, https://investors.amylyx.com/news-events/events, and will be available for replay for 90 days following the events.

About Amylyx Pharmaceuticals

Amylyx is committed to the discovery and development of new treatment options for communities with high unmet needs, including people living with serious and fatal diseases. The Company has preclinical or clinical development programs underway in neurodegenerative, neuroendocrine, and endocrine diseases. Since its founding, Amylyx has been guided by science to address unanswered questions, keeping communities at the heart and center of all decisions. Amylyx is headquartered in Cambridge, Massachusetts. For more information, visit amylyx.com and follow us on LinkedIn and X. For investors, please visit investors.amylyx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240828586290/en/

Media

Amylyx Media Team

+1 (857) 799-7274

amylyxmediateam@amylyx.com



Investors

Lindsey Allen

Amylyx Pharmaceuticals, Inc.

+1 (857) 320-6244

Investors@amylyx.com

Source: Amylyx Pharmaceuticals, Inc.

FAQ

When is Amylyx Pharmaceuticals (AMLX) participating in the Morgan Stanley Global Healthcare Conference?

Amylyx Pharmaceuticals (AMLX) is participating in the Morgan Stanley 22nd Annual Global Healthcare Conference on Thursday, September 5, 2024, at 1:50pm ET.

What investor conferences is Amylyx Pharmaceuticals (AMLX) attending in September 2024?

Amylyx Pharmaceuticals (AMLX) is attending three investor conferences in September 2024: Morgan Stanley Global Healthcare Conference, Baird Global Healthcare Conference, and H.C. Wainwright Global Investment Conference.

Where can I watch the webcasts of Amylyx Pharmaceuticals' (AMLX) investor conference presentations?

Webcasts of Amylyx Pharmaceuticals' (AMLX) investor conference presentations can be accessed under the 'Events and Presentations' section in the Investor area of the company's website at https://investors.amylyx.com/news-events/events.

How long will the recordings of Amylyx Pharmaceuticals' (AMLX) investor conference presentations be available?

The recordings of Amylyx Pharmaceuticals' (AMLX) investor conference presentations will be available for replay for 90 days following each event.